Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure

The US FDA defines modified risk tobacco products (MRTPs) as products that aim to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products.  Establishing a product’s potential as an MRTP requires scientific substantiation including toxicity studies an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:F1000Res
Autori principali: Boué, Stéphanie, Exner, Thomas, Ghosh, Samik, Belcastro, Vincenzo, Dokler, Joh, Page, David, Boda, Akash, Bonjour, Filipe, Hardy, Barry, Vanscheeuwijck, Patrick, Hoeng, Julia, Peitsch, Manuel
Natura: Artigo
Lingua:Inglês
Pubblicazione: F1000Research 2017
Soggetti:
Method Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657032/
https://ncbi.nlm.nih.gov/pubmed/29123642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.10493.2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi